FzioMed raises $10 million:
This article was originally published in Clinica
FzioMed has raised $10 million through a private placement, enabling it to advance development of its Oxiplex adhesion barrier technology and accelerate European sales plans. Oxiplex is the San Luis Obispo, California-based company's patented polymer technology, which is aimed at a range of targeted medical applications and markets. Oxiplex was recently granted CE mark certification for use in spine, abdominal and pelvic surgery.